Nucleic acids for the treatment of HMGB1-related pathologies

Details for Australian Patent Application No. 2005259381 (hide)

Owner Creabilis Therapeutics S.P.A.

Inventors Fumero, Silvano; Bianchi, Marco, E.; Sapio, Roberto; Barone, Domenico, G.; Bucci, Enrico, M.; Musumeci, Domenica; Valente, Margherita

Agent Davies Collison Cave

Pub. Number AU-A-2005259381

PCT Pub. Number WO2006/002971

Priority 60/646,586 26.01.05 US; 60/584,678 02.07.04 US

Filing date 4 July 2005

Wipo publication date 12 January 2006

International Classifications

A61K 31/00 (2006.01)

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/002971 Priority application(s): WO2006/002971

27 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259386-Canine osteoarthritis diet formulation

2005259346-Detection of tuberculosis and infection by mycobacterium tuberculosis using HBHA